Global Female Infertility Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Female Infertility Drugs
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Female Infertility Drugs by Type
- 1.3.1 Overview: Global Female Infertility Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Female Infertility Drugs Consumption Value Market Share by Type in 2023
- 1.3.3 Parenteral
- 1.3.4 Oral
- 1.3.5 Others
- 1.4 Global Female Infertility Drugs Market by Application
- 1.4.1 Overview: Global Female Infertility Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Ovarian Hyperstimulation Syndrome
- 1.4.3 Multiple-gestation Pregnancies
- 1.4.4 Multiple-birth Infants
- 1.4.5 Premature Labor
- 1.4.6 Low Birth Weight
- 1.4.7 Risk of Cesarean Delivery
- 1.5 Global Female Infertility Drugs Market Size & Forecast
- 1.6 Global Female Infertility Drugs Market Size and Forecast by Region
- 1.6.1 Global Female Infertility Drugs Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Female Infertility Drugs Market Size by Region, (2019-2030)
- 1.6.3 North America Female Infertility Drugs Market Size and Prospect (2019-2030)
- 1.6.4 Europe Female Infertility Drugs Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Female Infertility Drugs Market Size and Prospect (2019-2030)
- 1.6.6 South America Female Infertility Drugs Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Female Infertility Drugs Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Allergan Plc
- 2.1.1 Allergan Plc Details
- 2.1.2 Allergan Plc Major Business
- 2.1.3 Allergan Plc Female Infertility Drugs Product and Solutions
- 2.1.4 Allergan Plc Female Infertility Drugs Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Allergan Plc Recent Developments and Future Plans
- 2.2 Ferring BV
- 2.2.1 Ferring BV Details
- 2.2.2 Ferring BV Major Business
- 2.2.3 Ferring BV Female Infertility Drugs Product and Solutions
- 2.2.4 Ferring BV Female Infertility Drugs Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Ferring BV Recent Developments and Future Plans
- 2.3 Merck KGaA
- 2.3.1 Merck KGaA Details
- 2.3.2 Merck KGaA Major Business
- 2.3.3 Merck KGaA Female Infertility Drugs Product and Solutions
- 2.3.4 Merck KGaA Female Infertility Drugs Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Merck KGaA Recent Developments and Future Plans
- 2.4 Novartis AG
- 2.4.1 Novartis AG Details
- 2.4.2 Novartis AG Major Business
- 2.4.3 Novartis AG Female Infertility Drugs Product and Solutions
- 2.4.4 Novartis AG Female Infertility Drugs Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Novartis AG Recent Developments and Future Plans
- 2.5 Sanofi
- 2.5.1 Sanofi Details
- 2.5.2 Sanofi Major Business
- 2.5.3 Sanofi Female Infertility Drugs Product and Solutions
- 2.5.4 Sanofi Female Infertility Drugs Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Sanofi Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Female Infertility Drugs Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Female Infertility Drugs by Company Revenue
- 3.2.2 Top 3 Female Infertility Drugs Players Market Share in 2023
- 3.2.3 Top 6 Female Infertility Drugs Players Market Share in 2023
- 3.3 Female Infertility Drugs Market: Overall Company Footprint Analysis
- 3.3.1 Female Infertility Drugs Market: Region Footprint
- 3.3.2 Female Infertility Drugs Market: Company Product Type Footprint
- 3.3.3 Female Infertility Drugs Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Female Infertility Drugs Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Female Infertility Drugs Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Female Infertility Drugs Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Female Infertility Drugs Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Female Infertility Drugs Consumption Value by Type (2019-2030)
- 6.2 North America Female Infertility Drugs Consumption Value by Application (2019-2030)
- 6.3 North America Female Infertility Drugs Market Size by Country
- 6.3.1 North America Female Infertility Drugs Consumption Value by Country (2019-2030)
- 6.3.2 United States Female Infertility Drugs Market Size and Forecast (2019-2030)
- 6.3.3 Canada Female Infertility Drugs Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Female Infertility Drugs Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Female Infertility Drugs Consumption Value by Type (2019-2030)
- 7.2 Europe Female Infertility Drugs Consumption Value by Application (2019-2030)
- 7.3 Europe Female Infertility Drugs Market Size by Country
- 7.3.1 Europe Female Infertility Drugs Consumption Value by Country (2019-2030)
- 7.3.2 Germany Female Infertility Drugs Market Size and Forecast (2019-2030)
- 7.3.3 France Female Infertility Drugs Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Female Infertility Drugs Market Size and Forecast (2019-2030)
- 7.3.5 Russia Female Infertility Drugs Market Size and Forecast (2019-2030)
- 7.3.6 Italy Female Infertility Drugs Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Female Infertility Drugs Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Female Infertility Drugs Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Female Infertility Drugs Market Size by Region
- 8.3.1 Asia-Pacific Female Infertility Drugs Consumption Value by Region (2019-2030)
- 8.3.2 China Female Infertility Drugs Market Size and Forecast (2019-2030)
- 8.3.3 Japan Female Infertility Drugs Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Female Infertility Drugs Market Size and Forecast (2019-2030)
- 8.3.5 India Female Infertility Drugs Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Female Infertility Drugs Market Size and Forecast (2019-2030)
- 8.3.7 Australia Female Infertility Drugs Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Female Infertility Drugs Consumption Value by Type (2019-2030)
- 9.2 South America Female Infertility Drugs Consumption Value by Application (2019-2030)
- 9.3 South America Female Infertility Drugs Market Size by Country
- 9.3.1 South America Female Infertility Drugs Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Female Infertility Drugs Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Female Infertility Drugs Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Female Infertility Drugs Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Female Infertility Drugs Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Female Infertility Drugs Market Size by Country
- 10.3.1 Middle East & Africa Female Infertility Drugs Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Female Infertility Drugs Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Female Infertility Drugs Market Size and Forecast (2019-2030)
- 10.3.4 UAE Female Infertility Drugs Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Female Infertility Drugs Market Drivers
- 11.2 Female Infertility Drugs Market Restraints
- 11.3 Female Infertility Drugs Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Female Infertility Drugs Industry Chain
- 12.2 Female Infertility Drugs Upstream Analysis
- 12.3 Female Infertility Drugs Midstream Analysis
- 12.4 Female Infertility Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Female Infertility Drugs market size was valued at USD 4771 million in 2023 and is forecast to a readjusted size of USD 6963.6 million by 2030 with a CAGR of 5.6% during review period.
Female infertility refers to infertility in women. It affects an estimated 48 million women,with the highest prevalence of infertility affecting people in South Asia, Sub-Saharan Africa, North Africa/Middle East, and Central/Eastern Europe and Central Asia.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Female Infertility Drugs industry chain, the market status of Ovarian Hyperstimulation Syndrome (Parenteral, Oral), Multiple-gestation Pregnancies (Parenteral, Oral), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Female Infertility Drugs.
Regionally, the report analyzes the Female Infertility Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Female Infertility Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Female Infertility Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Female Infertility Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Parenteral, Oral).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Female Infertility Drugs market.
Regional Analysis: The report involves examining the Female Infertility Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Female Infertility Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Female Infertility Drugs:
Company Analysis: Report covers individual Female Infertility Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Female Infertility Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Ovarian Hyperstimulation Syndrome, Multiple-gestation Pregnancies).
Technology Analysis: Report covers specific technologies relevant to Female Infertility Drugs. It assesses the current state, advancements, and potential future developments in Female Infertility Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Female Infertility Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Female Infertility Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Parenteral
Oral
Others
Market segment by Application
Ovarian Hyperstimulation Syndrome
Multiple-gestation Pregnancies
Multiple-birth Infants
Premature Labor
Low Birth Weight
Risk of Cesarean Delivery
Market segment by players, this report covers
Allergan Plc
Ferring BV
Merck KGaA
Novartis AG
Sanofi
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Female Infertility Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Female Infertility Drugs, with revenue, gross margin and global market share of Female Infertility Drugs from 2019 to 2024.
Chapter 3, the Female Infertility Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Female Infertility Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Female Infertility Drugs.
Chapter 13, to describe Female Infertility Drugs research findings and conclusion.